Interactions between ACE inhibitors and classical antiepileptic drugs in the mouse maximal electroshock seizures

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 1, 2011, Pages 152-156

  Łukawski, Krzysztof ^a   Jakubus, Tomasz ^a   Janowska, Agnieszka ^a   Czuczwar, Stanisław J ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiepileptic drugs; Cilazapril; Enalapril; Maximal electroshock; Pharmacodynamic interaction

Indexed keywords

CARBAMAZEPINE; CILAZAPRIL; ENALAPRIL; ENARENAL; INHIBANCE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROATE MAGNESIUM;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; EXCITATION AND STIMULATION; MALE; MAXIMAL ELECTROSHOCK SEIZURE; MEMORY CONSOLIDATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROSHOCK; MALE; MICE; SEIZURES;

MUS;

EID: 80053127240     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.030     Document Type: Article

References (42)

1. S.A. Atlas The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition J Manag Care Pharm 13 Suppl B 2007 9 20
2. G. Czechowska, M. Dziki, T. Pietrasiewicz, Z. Kleinrok, W.A. Turski, and S.J. Czuczwar Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice Eur J Pharmacol 232 1993 59 64 (Pubitemid 23056997)
3. S.J. Czuczwar, H.H. Frey, and W. Löscher Antagonism of N-methyl-d, l-aspartic acid-induced convulsions by antiepileptic drugs and other agents Eur J Pharmacol 108 1985 273 280 (Pubitemid 15130318)
4. S.J. Czuczwar, M. Świa̧der, H. Kuźniar, M. Ga̧sior, and Z. Kleinrok LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs Eur J Pharmacol 359 1998 103 109 (Pubitemid 28513004)
5. D. De Bundel, I. Smolders, P. Vanderheyden, and Y. Michotte Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy CNS Neurosci Ther 14 2008 315 339
6. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International Union of Pharmacology. XXIII. The angiotensin II receptors Pharmacol Rev 52 2000 415 472
7. J.S. Duncan, J.W. Sander, S.M. Sisodiya, and M.C. Walker Adult epilepsy Lancet 367 2006 1087 1100
8. M.D. Evered, M.M. Robinson, and M.A. Richardson Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain Eur J Pharmacol 68 1980 443 449 (Pubitemid 11197456)
9. A. Gaitatzis, K. Carroll, A. Majeed, and J.W. Sander The epidemiology of the comorbidity of epilepsy in the general population Epilepsia 45 2004 1613 1622 (Pubitemid 39648287)
10. 1 receptor antagonist telmisartan administered peripherally inhibits central responses to Angiotensin II in conscious rats J Pharmacol Exp Ther 298 2001 62 70 (Pubitemid 32574511)
11. H.J. Gomez, V.J. Cirillo, and J.D. Irvin Enalapril: a review of human pharmacology Drugs 30 Suppl 1 1985 13 24 (Pubitemid 15249106)
12. V. Gross, E. Treher, K. Haag, W. Neis, U. Wiegand, and J. Schölmerich Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848) J Hepatol 17 1993 40 47 (Pubitemid 23037976)
13. N. Hirawa, Y. Uehara, Y. Kawabata, A. Numabe, T. Gomi, and T. Ikeda Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats Hypertension 34 1999 496 502 (Pubitemid 29426770)
14. J.G. Jefferys Mechanisms and experimental models of seizure generation Curr Opin Neurol 11 1998 123 127 (Pubitemid 28159697)
15. S. Jouquey, M.N. Mathieu, G. Hamon, and C. Chevillard Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats Neuropharmacology 34 1995 1689 1692 (Pubitemid 26005616)
16. J.G. Kelly, and K. O'Malley Clinical pharmacokinetics of the newer ACE inhibitors A Rev Clin Pharmacokinet 19 1990 177 196 (Pubitemid 20281449)
17. W. Lasoń, M. Dudra-Jastrzȩbska, K. Rejdak, and S.J. Czuczwar Basic mechanisms of antiepileptic drugs and their pharmacokinetic/ pharmacodynamic interactions: an update Pharmacol Rep 63 2011 271 292
18. J.T. Litchfield, and F. Wilcoxon A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 96 1949 99 113
19. W. Löscher Basic pharmacology of valproate CNS Drugs 10 2002 669 694
20. W. Löscher, and U. Ebert The role of the piriform cortex in kindling Prog Neurobiol 50 1996 427 481 (Pubitemid 27032263)
21. W. Löscher, C.P. Fassbender, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models Epilepsy Res 8 1991 79 94
22. K. Łukawski, T. Jakubus, G. Raszewski, and S.J. Czuczwar Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model J Neural Transm 117 2010 1161 1166
23. 1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock Eur J Pharmacol 640 2010 172 177
24. J.J. Łuszczki, K.K. Borowicz, M. Świa̧der, and S.J. Czuczwar Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis Epilepsia 44 2003 489 499
25. B.S. Meldrum Amino acid neurotransmitters and new approaches to anticonvulsant drug action Epilepsia 25 Suppl 2 1984 S140-S9
26. F.J. Minano, J.S. Serrano, M. Sancibrian, and M.I. Serrano Effect of peptidyl-dipeptidase inhibitors in experimental convulsions in mice Fundam Clin Pharmacol 1 1987 77 83 (Pubitemid 17162347)
27. P. Mojaverian, B.N. Swanson, and R.K. Ferguson Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia Eur J Pharmacol 98 1984 303 306 (Pubitemid 14156894)
28. T. Myhrer Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment Neurotoxicology 31 2010 629 638
29. A. Ravati, V. Junker, M. Kouklei, B. Ahlemeyer, C. Culmsee, and J. Krieglstein Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats Eur J Pharmacol 373 1999 21 33 (Pubitemid 29306707)
30. J. Tchekalarova, and V. Georgiev Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci 76 2005 955 970 (Pubitemid 39643397)
31. G.S. Thind Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics Cardiovasc Drugs Ther 4 1990 199 206 (Pubitemid 20108749)
32. R.L. Thunhorst, D.A. Fitts, and J.B. Simpson Angiotensin-converting enzyme in subfornical organ mediates captopril-induced drinking Behav Neurosci 103 1989 1302 1310 (Pubitemid 20079159)
33. T. Tsuchihashi, S. Kagiyama, Y. Ohya, I. Abe, and M. Fujishima Antihypertensive treatment and the responsiveness to glutamate in ventrolateral medulla Hypertension 31 1998 73 76 (Pubitemid 28124695)
34. R.K. Türker, M. Ilhan, and Z.S. Ercan Potentiation by angiotensin converting enzyme inhibitor, SQ, 14225, of the analgesic effect of morphine in mice Eur J Pharmacol 58 1979 99 100 (Pubitemid 9232954)
35. L. Turski, W. Niemann, and D.N. Stephens Differential effects of antiepileptic drugs and carbolines on seizures induced by excitatory amino acids Neuroscience 39 1990 799 807
36. T. Unger, E. Badoer, D. Ganten, R.E. Lang, and R. Rettig Brain angiotensin: pathways and pharmacology Circulation 77 1988 I40 I54
37. E. Urbańska, M. Dziki, Z. Kleinrok, S.J. Czuczwar, and W.A. Turski Influence of MK-801 on the anticonvulsant activity of antiepileptics Eur J Pharmacol 200 1991 277 282
38. P. Venault, G. Chapouthier, L. Prado de Carvalho, J. Simiand, M. Morre, and R.H. Dodd Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks Nature 321 1986 864 866 (Pubitemid 16097728)
39. J.F. Waterfall A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor Br J Clin Pharmacol 27 Suppl 2 1989 139S 150S (Pubitemid 19183680)
40. P.E. Williams, A.N. Brown, S. Rajaguru, R.J. Francis, G.E. Walters, and J. McEwen The pharmacokinetics and bioavailability of cilazapril in normal man Br J Clin Pharmacol 27 Suppl 2 1989 181S 188S (Pubitemid 19183685)
41. X. Wu, T. Kihara, H. Hongo, A. Akaike, T. Niidome, and H. Sugimoto Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion Br J Pharmacol 161 2010 33 50
42. K. Yamada, S. Uchida, S. Takahashi, M. Takayama, Y. Nagata, and N. Suzuki Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease Brain Res 1352 2010 176 186